Ignite Creation Date:
2025-12-24 @ 11:39 PM
Ignite Modification Date:
2026-01-03 @ 9:55 AM
Study NCT ID:
NCT00236951
Status:
COMPLETED
Last Update Posted:
2018-02-20
First Post:
2005-10-10
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Intravenous (IV) Iron vs. No Iron as the Treatment of Anemia in Cancer Patients Undergoing Chemotherapy and Erythropoietin Therapy
Sponsor:
American Regent, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
1VEN02023
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Marc Tokars, Senior Director of Clinical Operations
Old Organization:
Luitpold Pharmaceuticals, Inc.